News Pharma outperforms academia at reporting clinical trials - B... Only half of trials reported results despite EU rules
Partner Content Partner Content Carina Schey, University of Groningen, Orphan Drugs & Ra... Chair Invitation to Orphan Drugs & Rare Diseases 2018
Views & Analysis Innovation and collaboration: key catalysts for scientific b... During my time at Illumina I had a realisation: restricted access to data, and an industry-wide aversion to collaboration, was delaying and in some instances preventing the discovery of tre
Events Partner Content GCP Inspection Readiness Conference GCP Inspection Readiness is taking place in Brussels, Belgium from 20th - 22nd November 2018.
Events Partner Content 4th annual European Microbiome Congress Addressing the core challenges facing the microbiome industry, to translate academic research into clinically and commercially viable therapeutics.
Events Partner Content AI Applications Summit | Biopharma Discussing the practical steps for implementing AI
News MSD takes a $400m bite of SciBrunch's KRAS drug MSD has signed a license agreement for a KRAS G12D inhibitor from China's SciBrunch, paying $400m upfront for the preclinical candidate.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
